GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (LTS:0O9B) » Definitions » Quality Rank

Almirall (LTS:0O9B) Quality Rank


View and export this data going back to 2010. Start your Free Trial

What is Almirall Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Almirall Quality Rank Related Terms

Thank you for viewing the detailed overview of Almirall's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (LTS:0O9B) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (LTS:0O9B) » Definitions » Quality Rank
Comparable Companies
XMAD:FAE XMAD:RJF XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507 HKSE:03692 VTRS TSE:4523 BOM:500124 XPAR:IPN NSE:TORNTPHARM
Traded in Other Exchanges
LBTSF:USA ALM:Spain E2Z:Germany
Address
Ronda General Mitre 151, Barcelona, ESP, 08022
Website
http://www.almirall.es
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.